645 related articles for article (PubMed ID: 18567695)
21. [Antihypertensive therapy for refractory morning hypertension in patients on peritoneal dialysis].
Kuriyama S; Otsuka Y; Iida R; Kobayashi S; Yamagishi H; Hosoya T
Nihon Jinzo Gakkai Shi; 2005; 47(1):38-45. PubMed ID: 15754762
[TBL] [Abstract][Full Text] [Related]
22. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance.
Saudan P; Halabi G; Perneger T; Wasserfallen JB; Wauters JP; Martin PY;
J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432
[TBL] [Abstract][Full Text] [Related]
23. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
Gotsman I; Rubonivich S; Azaz-Livshits T
Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
[TBL] [Abstract][Full Text] [Related]
24. Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations.
Badve SV; Hawley CM; McDonald SP; Mudge DW; Rosman JB; Brown FG; Johnson DW;
Nephrol Dial Transplant; 2006 Mar; 21(3):776-83. PubMed ID: 16280374
[TBL] [Abstract][Full Text] [Related]
25. Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment.
Penne EL; Neumann J; Klein IH; Oey PL; Bots ML; Blankestijn PJ
J Nephrol; 2009; 22(2):208-15. PubMed ID: 19384838
[TBL] [Abstract][Full Text] [Related]
26. Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?
Koc Y; Unsal A; Basturk T; Sakaci T; Ahbap-Dal E; Sinangil-Arar A; Kose-Budak S; Kayabasi H
Nefrologia; 2012 May; 32(3):335-42. PubMed ID: 22508142
[TBL] [Abstract][Full Text] [Related]
27. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
Catapano F; Chiodini P; De Nicola L; Minutolo R; Zamboli P; Gallo C; Conte G
Am J Kidney Dis; 2008 Sep; 52(3):475-85. PubMed ID: 18468748
[TBL] [Abstract][Full Text] [Related]
28. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
[TBL] [Abstract][Full Text] [Related]
29. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.
Kiski D; Stepper W; Brand E; Breithardt G; Reinecke H
Nephrol Dial Transplant; 2010 Mar; 25(3):759-64. PubMed ID: 19903660
[TBL] [Abstract][Full Text] [Related]
30. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
31. A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients.
Kolesnyk I; Noordzij M; Dekker FW; Boeschoten EW; Krediet RT
Nephrol Dial Transplant; 2009 Jan; 24(1):272-7. PubMed ID: 18676349
[TBL] [Abstract][Full Text] [Related]
32. Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers.
Takeuchi K; Ideishi M; Tashiro T; Morishige N; Yamada T; Saku K; Urata H
Hypertens Res; 2005 Aug; 28(8):639-44. PubMed ID: 16392767
[TBL] [Abstract][Full Text] [Related]
33. Blood pressure control in kidney transplantation: therapeutic implications.
Premasathian NC; Muehrer R; Brazy PC; Pirsch JD; Becker BN
J Hum Hypertens; 2004 Dec; 18(12):871-7. PubMed ID: 15318162
[TBL] [Abstract][Full Text] [Related]
34. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
Han SW; Won YW; Yi JH; Kim HJ
Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
[TBL] [Abstract][Full Text] [Related]
35. Progress report on The Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) study: status at February 2004.
Hosohata K; Saito S; Asayama K; Ohkubo T; Kikuya M; Metoki H; Obara T; Kato T; Hashimoto J; Totsune K; Miura Y; Imai Y;
Clin Exp Hypertens; 2007 Jan; 29(1):69-81. PubMed ID: 17190733
[TBL] [Abstract][Full Text] [Related]
36. Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts.
Gradzki R; Dhingra RK; Port FK; Roys E; Weitzel WF; Messana JM
Am J Kidney Dis; 2001 Dec; 38(6):1240-4. PubMed ID: 11728956
[TBL] [Abstract][Full Text] [Related]
37. Early initiation of peritoneal dialysis in diabetic patients.
Coronel F; Cigarran S; Herrero JA
Scand J Urol Nephrol; 2009; 43(2):148-53. PubMed ID: 19085460
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
Jennings DL; Kalus JS; Coleman CI; Manierski C; Yee J
Diabet Med; 2007 May; 24(5):486-93. PubMed ID: 17367311
[TBL] [Abstract][Full Text] [Related]
39. Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.
McCall KL; Craddock D; Edwards K
Pharmacotherapy; 2006 Sep; 26(9):1297-306. PubMed ID: 16945052
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease.
Imaizumi S; Miura S; Nishikawa H; Iwata A; Zhang B; Kawamura A; Tsuchiya Y; Kumagai K; Matsuo K; Saku K
Hypertens Res; 2006 Mar; 29(3):135-41. PubMed ID: 16755148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
